Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NASDAQ:LFMD

LifeMD Q3 2026 Earnings Date & Estimates

LifeMD logo
$2.12 +0.04 (+1.92%)
Closing price 10/27/2026 04:00 PM Eastern
Extended Trading
$2.16 +0.04 (+2.12%)
As of 10/27/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeMD is estimated to report Q3 2026 earnings on Monday, November 9, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET

What Analysts Expect from LifeMD in Q3 2026

LifeMD is expected to post earnings of -$0.14 per share on revenue of $48.80 million. In the same quarter a year earlier LifeMD reported -$0.10 per share on revenue of $60.17 million. LifeMD last reported on August 5, 2026, posting -$0.16 per share and missing the -$0.1457 consensus estimate. LifeMD has beaten the consensus EPS estimate in 2 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.14
Expected Revenue
$48.80 million
Prior-Year EPS
-$0.10
Prior-Year Revenue
$60.17 million
Expected Revenue Growth
-18.9%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.16 (Missed by -$0.0143)
Last Quarter Revenue
$47.28 million
EPS Beat Rate
2 of last 8 quarters

LifeMD Q3 2026 Earnings FAQ

LifeMD (NASDAQ:LFMD) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

LifeMD's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect LifeMD to post earnings of -$0.14 per share for Q3 2026.

The consensus revenue estimate for LifeMD is $48.80 million for Q3 2026.

LifeMD Earnings Headlines

Critical Review: 20/20 Biolabs (NASDAQ:AIDX) & LifeMD (NASDAQ:LFMD)
My next big call (under $1)
17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community before the big move happened. Now, I'm making my next big call. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage. With Bitcoin well off its highs and fear still hanging over the market, this is the exact environment where my biggest winners have been found.tc pixel
Financial Analysis: GeneDx (NASDAQ:WGS) versus LifeMD (NASDAQ:LFMD)
See More LifeMD Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like LifeMD? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LifeMD and other key companies, straight to your email.

About LifeMD

LifeMD (NASDAQ:LFMD) is a direct-to-consumer telehealth company that provides virtual medical care, prescription treatments and related health services through its digital platform. The company connects patients with licensed health care providers for online consultations, ongoing care and, when clinically appropriate, prescription medications.

Its services include virtual primary care and programs focused on areas such as weight management, men's health, women's health, dermatology and chronic-care support. LifeMD also operates specialized digital health offerings, including Rex MD, which focuses on men's health, and Shapiro MD, a hair-loss treatment platform. Services and treatment availability may vary by state and individual patient eligibility.

The company was formerly known as Conversion Labs and adopted the LifeMD name as it expanded its telehealth business. LifeMD primarily serves patients in the United States through online consultations, care coordination and pharmacy fulfillment arrangements. The company's leadership has included Justin Schreiber, who has served as chief executive officer.

View LifeMD Profile